Press Releases from Scil Technology GmbH (2 total)
Nanohale AG acquires R&D and service units of Scil Technology GmbH
- Transaction creates new Nanohale subsidiary named Formycon GmbH -
Dortmund and Martinsried, Germany, January 9, 2012 – Scil Technology GmbH and Nanohale AG today announced that Nanohale has acquired the entire R&D, contract development and manufacturing organization of Scil Technology GmbH in an asset deal, effective December 31, 2011. Employees and inventory of Scil Technology GmbH have become part of Formycon GmbH, a fully-owned subsidiary of Nanohale AG. The rights…
SANOFI LICENSES WORLDWIDE RIGHTS ON REGENERATIVE TREATMENT FOR OSTEOARTHRITIS AN …
Martinsried, Germany, December 20, 2011 – Scil Technology GmbH, a privately held biopharmaceutical company with core expertise in protein drug development, formulation and analytics, today announced that Sanofi (EURONEXT: SAN and NYSE: SNY) has exclusively licensed Scil Technology’s program for the regenerative treatment of osteoarthritis and cartilage disorders.
Under the agreement, SCIL Technology will receive an upfront payment and potential milestone payments totaling up to EUR 180 million. Moreover, the…
